Arca Biopharma reported $0 in Interest Expense on Debt for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US USD 368M 40M
Arca Biopharma ABIO:US USD 0 0
Biogen BIIB:US USD 59.9M 5.9M
Bristol Myers Squibb BMY:US USD 299M 14M
Cytokinetics CYTK:US USD 6.8M 4M
Gilead Sciences GILD:US USD 229M 13M
Laboratory Of America LH:US USD 46.3M 3.8M
Myriad Genetics MYGN:US USD 800K 200K
Pfizer PFE:US USD 311M 18M
United Therapeutics UTHR:US USD 9.2M 3M